Terms: = Ovarian cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Prognosis
11 results:
1. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/smad2/3 signaling pathway in ovarian cancer.
Song G; Sun Z; Chu M; Zhang Z; Chen J; Wang Z; Zhu X
BMC Cancer; 2024 Jan; 24(1):122. PubMed ID: 38267923
[TBL] [Abstract] [Full Text] [Related]
2. The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance
Li X; Gao X; Yuan J; Wang F; Xu X; Wang C; Liu H; Guan W; Zhang J; Xu G
Front Endocrinol (Lausanne); 2022; 13():950345. PubMed ID: 36120434
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA PVT1 promotes the progression of ovarian cancer by activating TGF-β pathway via miR-148a-3p/AGO1 axis.
Wu Y; Gu W; Han X; Jin Z
J Cell Mol Med; 2021 Sep; 25(17):8229-8243. PubMed ID: 34288373
[TBL] [Abstract] [Full Text] [Related]
4. SCRIB Is Involved in the Progression of ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients.
Hussein UK; Ahmed AG; Choi WK; Kim KM; Park SH; Park HS; Noh SJ; Lee H; Chung MJ; Moon WS; Kang MJ; Cho DH; Jang KY
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803371
[TBL] [Abstract] [Full Text] [Related]
5. KRT7 promotes epithelial‑mesenchymal transition in ovarian cancer via the TGF‑β/smad2/3 signaling pathway.
An Q; Liu T; Wang MY; Yang YJ; Zhang ZD; Liu ZJ; Yang B
Oncol Rep; 2021 Feb; 45(2):481-492. PubMed ID: 33416175
[TBL] [Abstract] [Full Text] [Related]
6. Nucleosome Assembly Protein 1-Like 3 Enhances Cisplatin Resistance of ovarian cancer Cell by Activating Transforming Growth Factor-Beta Pathway.
Mo X; Sun J; Xu L; Zhao N; Yan M; Li H; Qin P
J Interferon Cytokine Res; 2020 Jul; 40(7):333-340. PubMed ID: 32701410
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer.
Zhou H; Sun Z; Li S; Wang X; Zhou X
Cancer Gene Ther; 2018 Feb; 25(1-2):39-46. PubMed ID: 29234152
[TBL] [Abstract] [Full Text] [Related]
8. DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
[TBL] [Abstract] [Full Text] [Related]
9. The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.
Peng J; Yoshioka Y; Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Kharma B; Murakami R; Abiko K; Murphy SK; Konishi I
Mol Carcinog; 2016 Apr; 55(4):335-45. PubMed ID: 25663289
[TBL] [Abstract] [Full Text] [Related]
10. TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.
Cheng JC; Auersperg N; Leung PC
PLoS One; 2012; 7(8):e42436. PubMed ID: 22905131
[TBL] [Abstract] [Full Text] [Related]
11. Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells.
Li FF; Liu JJ; Liu DW; Lin B; Hao YY; Cong JP; Zhu LC; Gao S; Zhang SL; Iwamori M
Int J Oncol; 2012 Apr; 40(4):1196-202. PubMed ID: 22179544
[TBL] [Abstract] [Full Text] [Related]
